Compare Stocks: ALNY vs. INSM vs. ROIV vs. INCY
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
ALNYINSMROIVINCY
Market Snapshot
Current market context for the selected companies.
ALNY
$236.22
Market Cap
$31.61B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
INSM
$125.77
Market Cap
$27.47B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
ROIV
$36.30
Market Cap
$26.22B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
INCY
$127.81
Market Cap
$25.91B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
Performance
Absolute returns and relative performance versus SPY.
| Metric | ALNY | INSM | ROIV | INCY |
|---|---|---|---|---|
| 1 Month | -12.1% | +17.1% | +3.4% | +9.5% |
| 1 Month vs SPY | -15.8% | +13.4% | -0.3% | +5.8% |
| 3 Months | -21.4% | +14.8% | +17.6% | +31.2% |
| 3 Months vs SPY | -24.5% | +11.7% | +14.5% | +28.1% |
| 6 Months | -29.7% | -23.7% | +33.7% | +26.1% |
| 6 Months vs SPY | -40.8% | -34.8% | +22.6% | +15.1% |
| 1 Year | -48.5% | -2.8% | +209.7% | +48.3% |
| 1 Year vs SPY | -68.5% | -22.8% | +189.7% | +28.3% |
| 2 Years | -11.9% | +65.1% | +224.4% | +105.6% |
| 2 Years vs SPY | -50.1% | +26.9% | +186.3% | +67.5% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.